Gubra A/S

Copenhagen Stock Exchange GUBRA.CO

Gubra A/S Operating Income Margin for the year ending December 31, 2023: -24.11%

Gubra A/S Operating Income Margin is -24.11% for the year ending December 31, 2023, a -717.83% change year over year. Operating Income Ratio is the proportion of a company's operating income to its net sales, measuring the efficiency of its core business operations in generating profits.
  • Gubra A/S Operating Income Margin for the year ending December 31, 2022 was 3.90%, a -88.78% change year over year.
  • Gubra A/S Operating Income Margin for the year ending December 31, 2021 was 34.77%, a 298.19% change year over year.
  • Gubra A/S Operating Income Margin for the year ending December 31, 2020 was 8.73%.
Key data
Date Operating Income Margin EBT Margin Net Income Margin EBITDA Margin
Market news
Copenhagen Stock Exchange: GUBRA.CO

Gubra A/S

CEO Mr. Henrik Blou
IPO Date April 4, 2023
Location Denmark
Headquarters Hørsholm Kongevej 11B
Employees 235
Sector Health Care
Industries
Biotechnology Pharmaceuticals Research & Consulting
Description

Gubra A/S operates as a biotech company with two primary areas of business: pre-clinical contract research (CRO) services and proprietary early target and drug discovery programs. The CRO segment offers pre-clinical contract research and development services for the pharmaceutical and biotechnology industry, as well as provides services in vivo pharmacology, tissue research, assays, molecular pharmacology, bioanalysis, sequencing (NGS), and 2D and 3D imaging. The company was incorporated in 2008 and is based in Horsholm, Denmark.

StockViz Staff

January 15, 2025

Any question? Send us an email